 |
|
| Science Forum Index » Medicine - Lyme Forum » UConn wants a new pediatric assault center- update,... |
|
Page 1 of 1 |
|
| Author |
Message |
| Mort Zuckerman... |
 Posted: Thu Oct 22, 2009 3:11 am |
|
|
|
Guest
|
To: Durland.fish at (no spam) yale.edu, Aag1 at (no spam) columbia.edu, gary_wormser at (no spam) nymc.edu,
scientificintegrity at (no spam) ostp.gov, pkrugman at (no spam) princeton.edu,
Stanley.fish at (no spam) fiu.edu, emcsweegan at (no spam) niaid.nih.gov, afauci at (no spam) niaid.nih.gov,
SpinLyme at (no spam) yahoogroups.com, kshepard at (no spam) calea.org, fitzmas at (no spam) gmail.com,
patrick.fitzgerald at (no spam) usdoj.gov, modelt1918 at (no spam) sbcglobal.net,
jdrazen at (no spam) nejm.org, letters at (no spam) courant.com, Jgerberding at (no spam) cdc.gov,
michael.cole at (no spam) po.state.ct.us, conndcj at (no spam) po.state.ct.us, executive-
editor at (no spam) nytimes.com, managing-editor at (no spam) nytimes.com, news-
tips at (no spam) nytimes.com, bizday at (no spam) nytimes.com, foreign at (no spam) nytimes.com,
national at (no spam) nytimes.com, dvbid at (no spam) cdc.gov, brigidcallahan at (no spam) optonline.net,
trvl at (no spam) hotmail.com, illinoislyme at (no spam) aol.com, jlender at (no spam) courant.com,
tinajgarcia at (no spam) yahoo.com, jhornberger at (no spam) fff.org, thomas.carson at (no spam) usdoj.gov,
thomas.ryan at (no spam) po.state.ct.us, kurtzh at (no spam) washpost.com,
georgewill at (no spam) washpost.com, pj at (no spam) allegorypress.com,
commissioner.dcf at (no spam) po.state.ct.us, bransfield at (no spam) comcast.net,
vtsherr at (no spam) comcast.net, oca at (no spam) po.state.ct.us, freethinker at (no spam) charter.net,
scott.murphy at (no spam) po.state.ct.us, governor.rell at (no spam) po.state.ct.us,
attorney.general at (no spam) po.state.ct.us, randall.samborn at (no spam) usdoj.gov,
Robert.shiller at (no spam) yale.edu, editor at (no spam) greenwich-post.com,
harold.koh at (no spam) yale.edu, sedmonds at (no spam) nswbc.org, rrmcgovern at (no spam) aol.com,
frich at (no spam) nytimes.com, dprice at (no spam) stmartin.edu
Cc: francam at (no spam) ucia.gov, dr-ahmadinejad at (no spam) president.ir,
eugenerobinson at (no spam) washpost.com, afauci at (no spam) niaid.nih.gov,
bmiller at (no spam) newstimes.com, trvl at (no spam) hotmail.com, rastro18 at (no spam) aol.com,
billcurryct at (no spam) gmail.com, amcguigan at (no spam) rms-law.com, rjmurzyn at (no spam) aol.com,
paulcraigroberts at (no spam) yahoo.com, sidney_blumenthal at (no spam) yahoo.com,
criminal.division at (no spam) usdoj.gov, karla.dobinski at (no spam) usdoj.gov,
christopher.christie at (no spam) usdoj.gov, richard.Levin at (no spam) yale.edu,
harold.koh at (no spam) yale.edu, james.phillips at (no spam) yale.edu, inquire at (no spam) aldf.com,
lyme at (no spam) idsociety.org, meganmcardle at (no spam) theatlantic.com,
bob.drogin at (no spam) latimes.com
Subject: UConn wants a new pediatric assault center- update, Hartford
Courant, 091022
Date: Oct 22, 2009 9:10 AM
http://www.actionlyme.org/Pam3Cys_Version15.htm
In this ^^^ report, you will see
OspA's association to cancer:
Joseph G. Tully and mycoplasma in cancer and effect on erythrocytes
(Chronic Fatigue)
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=9126441[uid]
Mycoplasma attaching to RBCs (causing Chronic Fatigue)
http://iai.asm.org/cgi/content/full/76/1/71/F1
------------------------
NEWS:
http://www.courant.com/health/hc-uconn-hospital-1022.artoct22,0,6957447,print.story
=======FACTS:
http://www.actionlyme.org/UCONN_NO_HOSPITAL.htm
UConn Health Center - which now expects a new $605 million hospital
for committing an international mass-murder crime - should not get a
dime because they're part of a criminal cabal who works for
BigInsurance and the CT AG sued them over their international Lyme
crymes.
http://www.actionlyme.org/UCONNS_ABUSE_OF_CZECH_CHILDREN.htm
The technical term for what they did to these ▲ kids is "assault."
They KNEW this OspA vaccine did not
work. They KNEW they could not read
their Western Blots in OspA vaccinated
people:
1) SCHOEN and PERSING, with JOHN ANDERSON,1996 - the RICO report:
http://jcm.asm.org/cgi/reprint/35/1/233?view=long&pmid=8968914
2) SCHOEN AND PERSING IN THEIR 1996 RICO METHOD PATENT:
The Dave Persing, Mayo Clinic FRAUD Patent-6,045,804
http://patft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=6045804.PN.&OS=PN/6045804&RS=PN/6045804
3) PERSING WITH SIGAL EXPLAINING THAT THE WESTERN BLOTS WERE
UNREADABLE, 2000:
http://www.journals.uchicago.edu/doi/pdf/10.1086/313920
4) Yale's ROBERT SCHOEN in the 1998 Munchausen's Book, instructing MDs
to blow off LYMErix systemically injured people ("but send the post-
vaccination blood to the Yale L2 Diagnostics RICO lab if you must
bother to be a physician"):
http://www.actionlyme.org/SCHOEN_INSTRUCTING_DOCS_TO_BLOW_OFF_LYMERIX_INJUREES.htm
http://www.actionlyme.org/MUNCHAUSENS.htm
================================================http://www.courant.com/news/health/hc-uconn-health-response-032.artmar25,0,3231102.story
HARTFORD HOSPITAL, UCONN HEALTH CENTER
UConn Officials: Rell's Stance On Hospital Merger A Mistake...
The reason UConn Health Center is financially floundering is because
they and their Friendly-Local-University-Partners-in-Crime, Yale, lost
out on over a billion dollars in grant money ($1.009 billion, to be
exact) from Sept 2007 to June 2008.
The NIH is sick of funding no treatments and no outcomes and no
benefits to the humans for whom the US Department of Health and Human
Services allegedly work.
The NIH gave out $400 million to everyone-but-Yale-and-UConn, and the
Howard Hughes Institute gave out $600 million to everyone-but-Yale-and-
UConn. And the Department of Agriculture took Plum Stupid Island away
from Yale because of all their bumbling accidental releases, Lyme
Disease almost certainly being one of them, according to outbreak-
range studies performed by SUNY, Stony Brook [PubMed ID: 3577493].
UConn Health Center staff participated in a crime over which the CT
Attorney General, Richard Blumenthal, sued civilly, and subjects of
the suit included employees of New York Medical College (NYMC),
Valhalla, NY, a former Catholic Medical College.
In other words, if UConn Health Center were to be given a new
hospital, it would be a reward for committing a huge international
crime, and a crime in which UConn and Yale were partners with
BigInsurance, namely Kaiser-Permanente (who is still at NYMC literally
training new MDs) and American International Group.
Mr. Blumenthal is a former US Attorney and his staff lawyers first
told me in 2003 to file it as a scientific fraud and racketeering
crime with the USDOJ in New Haven. Since the New Haven USDOJ refused
to prosecute the crime, Mr. Blumenthal’s office sued civilly for
“exclusionary practices” and “monopolization” of the “Lyme Disease
Guidelines” three years later.
In other words, “scientific fraud and racketeering.”
http://www.actionlyme.org/USDOJ_COMPLAINT_RICO.htm
The last failed HIV vaccine trial, in which the NIH was a participant,
had to be stopped in the Spring of 2008 because Yale and UConn never
told anyone that their nearly identical vaccine (to the HIV vaccine,
Pam3Cys), LYMErix (Pam3Cys), “approved” by the FDA in December 1998,
was never a vaccine and created the same immune suppression outcomes
as the failed HIV vaccine and the failed tuberculosis vaccines:
http://www.actionlyme.org/PAM3CYS_IMMUNE_SUPPRESSION.htm
http://www.actionlyme.org/FUNGAL_VACCINES.htm
Yale and UConn knew LYMErix Pam3Cys was never a vaccine and they know
“Lyme Disease” is not an autoimmune arthritis in a knee, which they
now claim. Yale and UConn used to call it The New Great Imitator,
http://www.actionlyme.org/CHP_9_IDSA_REVIEWS.htm
because it produced outcomes like ALS, MS, Lupus, and Cancer. Later
we found out that OspA or Yale’s LYMErix “vaccine” itself, Pam3Cys,
caused most of these New Great Imitators because it suppressed the
immune system or gummed up the natural course of events in developing
immunity.
LYMErix turned off the immune system resulting in the activation of
latent viruses of all kinds -resulting in Cancer and MS - and it also
tolerized people to fungal antigens or fungal infections, which are
thought to be responsible for ALS in some cases.
It was that big of a lie and a global disaster costing the entire
world over 10 years in wasted lives, time and misdirected scientific
discovery. Yale and UConn lied to the FDA about the outcomes of
LYMErix.
http://www.actionlyme.org/DICKSON_FDA_SUBMISSION_FULL.htm
If they had not decided to lie about the outcomes of these vaccines
ahead of time, they would have stopped in 1998 or earlier to discover
why OspA caused a disease like chronic Lyme. Instead, Yale and UConn
further tortured the victims of their crimes, slandering and
persecuting LYMErix and Lyme victims and activists, if not worse.
Here is the overall scheme of the Lyme RICO and how it related to
BigInsurance:
The Lyme crymes and the cabal are about an intended monopoly on vector
borne diseases "test kits" and "vaccines" and could not have happened
without the Bayh-Dole Act.
The monopoly involved Kaiser-Permanente (still) at New York Medical
College and the deal was: No one is allowed to have any illness signs
nor is treatment to be paid for, until the alleged "vaccine" is ready,
and then everyone will be notified about how serious that particular
vector borne disease is, and that they better get the "vaccine.”
THE DATA UCONN, IDSA, YALE, and NYMC REFUSED TO TURN OVER TO CT
ATTORNEY GENERAL RICHARD BLUMENTHAL:
1) “DEARBORN:”
There was a meeting of all the national labs who did Lyme testing in
1994 in Dearborn, Michigan, in which the labs were invited to
“participate in the proceedings.” The labs said at that meeting that
the new diagnostic standard (blood test for Lyme) proposed by Allen
Steere (Yale) was between 8% and 22% accurate, or missed 92 to 78% of
all cases. In other words, there was no consensus, but we got this
standard anyway:
http://www.actionlyme.org/CRYMEDISEASE_CHP3_B.htm
Allen Steere went to Europe with bogus "high-passage" strains and
recombinant OspA
http://www.actionlyme.org/STEERE_IN_EUROPE.htm
with no lipid moiety attached, when the lipid end is the most
immunostimulatory (likeliest to
produce a lot of antibodies. This is how OspA and B were left out of
the new Dearborn
diagnostic standard which is based on STEERE IN EUROPE, fooling the
young lab
rat Frank Dressler ▼
◄"These fusion proteins contained the full-length OspA or OspB
sequence without the lipid moiety or signal sequence."
There's none of that strain B31 OspA in Europe - he says, based on
this study, and
OspA is a varying antigen, says CDC officer Alan Barbour:
http://www.actionlyme.org/BARBOUR_MUTANTS_1992.htm
That was how Allen Steere In Europe set up the bogus Dearborn
diagnostic standard for the monopoly.
One wonders how one study alone, by Allen Steere in Europe - ALONE -
abusing a young student, Frank Dressler, could possibly be the world's
diagnostic standard for "Lyme Disease," when the CDC says we are to
ignore sci-med reports from Europe (the reverse is clearly true- we
should ignore everything published in America).
http://www.actionlyme.org/CRYMEDISEASE_CHP3_B.htm
Mr. Blumenthal has this Dearborn booklet that shows the above is true,
since I gave his office a copy in 2003, at the time they referred me
to the USDOJ. You can be sure Gary Wormser of New York Medical
College never turned over to Mr. Blumenthal his own report which shows
that the Dearborn standard only detected 9/59 cases (in IgG), or
missed 85% of all cases, since the basis of the “guidelines” is this
1994 Dearborn “case definition.”
In other words, the “guidelines” are about a bogus entity, “Lyme
Disease” renamed and designed at Dearborn to suit BigInsurance’s
bottom line and the falsification of the outcome of Yale’s OspA-
patent, the LYMErix vaccine.
So, the testing for Lyme is fraudulent and was meant to set up a bogus
vaccine trial: If no one has “Lyme Disease” – and this new Dearborn
standard misses ~85% of all cases - then no one will have a “case” of
“Lyme Disease” after they were vaccinated with Yale’s vaccine,
LYMErix, and the vaccine will be shown to be “safe and effective.”
They committed this crime and we Lyme victims undid it. The vaccine
was removed from the market, but the diagnostic standard remains.
This Dearborn standard only detects the hypersensitivity (allergy)
form of Lyme that results in ONLY a bad knee, and no neurologic or
chronic fatigue signs.
Insurance companies did not want to pay for long term intravenous
treatment for Lyme, since the cost could be $100,000 per year. So,
Yale and UConn worked in cahoots with BigInsurance to narrow disease
definitions. It was a RICO that revolved around vector-borne
diseases, which this clique literally called “a gold mine of virulence
determinants” (vaccine candidates).
2) IDSA's TREATMENT FAILURE REPORTS:
LINK TO MEDLINE, ALL, "Reviews of Infectious Diseases" (the former
name of the IDSA journal), 1989 Supplement 6; this is the status
summary that led to the creation of the ALDF.com cabal at New York
Medical College with Kaiser-Permanente's takeover of "Lyme Disease"
It was John J. Connolly of CastleConnolly.com and the former
Chairman of the ALDF.com cabal, who sold out New York Medical College
to Kaiser. (Connolly is yet another disgrace-to-the-race, in addition
to McSweegan and "US Attorney" Kevin J. O'Connor of the DCF-Party-And-
Screw for the DCF-Rowlandgate "national string of pediatric jails"
enterprise, TREA.)
IDSA, the cabal, the ALDF.com; Yale, UConn and NYMC refused to turn
over to Mr. Blumenthal 20 or so of their own reports that shows that
the treatment of Lyme Disease (OspA-Relapsing Fever or Plum Island
Mycoplasmal Borreliosis) failed. Here are those publication numbers
by PubMed, the National Library of Medicine database
http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed :
a, b, c) CDC Officer and former Yale staffer, Allen Steere in 1994 and
1996, 3 reports which showed antibiotic treatment failure, to the tune
of about a 1/3 of all cases, even with his bogus, VARIABLE, OspA
primers:
PubMed ID: 8085687, 8272083, 8769624
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=8085687[uid]
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=8272083[uid]
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=8769624[uid]
At autopsy, lymphoid mononuclear cells were observed surrounding
the intracerebral vessels in one section. Using Dieterle silver stain,
a spirochete was present in the cortex and another was exterior to a
leptomeningeal vessel."
http://www.annals.org/cgi/content/full/121/8/560 (--Allen Steere)
d) CDC Officer Mark Klempner on intracellular spirochetes persisting
past treatment with ceftriaxone:
1634816;
full text- Fibroblasts protect the Lyme disease spirochete, Borrelia
burgdorferi, from ceftriaxone in vitro.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=1634816[uid]
e) CDC Officer and owner of the other, ImmuLyme, OspA patent, Alan
Barbour (vancomycin and mouse brains):
8913478; In vivo activities of ceftriaxone and vancomycin against
Borrelia spp. in the mouse brain and other sites.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=8913478[uid]
The failure of vancomycin in eradicating established infections in
immunodeficient mice was associated with the persistence of viable
spirochetes in the brain during antibiotic treatment.
[Now, remember, the spirochetes' OspA-shedding or auto-vaccination or
spirochetal blebbing of these fungal antigens (Pam3Cys-OspA) causes
immune-suppression. Chronic Lyme is like being continually auto-
vaccinated with OspA or Pam3Cys or LYMErix:
Says CDC Officer Alan Barbour:
Many researchers believe that the secret to B. burgdorferi's
infectivity and inflammatory capacity lies in the interaction of its
surface proteins with the host's immunological system. Yale researcher
Stephen Barthold, a veterinarian and professor of comparative medicine
who developed the first mouse model of Lyme disease, studies the
expression of B. burgdorferi surface proteins throughout various
stages of the spirochete's life cycle. He finds that during the early
stages of infection, B. burgdorferi avoids immune detection by
decreasing its expression of surface proteins or cloaking its
expressed surface proteins under a layer of slime. "It's using some
sort of stealth-bomber-type mechanism," he says. Or, using another
diversionary tactic called blebbing, the spirochete can pinch off bits
of its membrane in order to release its surface proteins. Explains
Barbour: "It's like a bacterial Star Wars defense program," in which
released surface proteins might intercept incoming host antibodies,
keeping the spirochete safe from immunological attack. ]
f) Russell Johnson, advisor to the ALDF.com (the original
“enterprise”) in a patent on chronic Lyme being due to chronic
infection:
US Patent: 4,721,617:
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=4,721,617.PN.&OS=PN/4,721,617&RS=PN/4,721,617
"The chronic forms of the disease such as arthritis (joint
involvement), acrodermatitis chronica atrophicans (skin involvement),
and Bannwarth's syndrome (neurological involvement) may last for
months to years and are associated with the persistence of the
spirochete…
"The infection may be treated at any time with antibiotics such as
penicillin, erythromycin, tetracycline, and ceftriaxone. Once
infection has occurred, however, the drugs may not purge the host of
the spirochete but may only act to control the chronic forms of the
disease.
Russell Johnson is also the editor of this 1976 textbook, The
Biology of Parasitic Spirochetes:
"The ability of the borrelia, especially tick-borne strains to
persist in the brain and in the eye after treatment with arsenic or
with penicillin or even after apparent cure is well known (1). The
persistence of treponemes after treatment of syphilis is a major area
which currently requires additional study (3,5,10,11)."
-Jay Sanford, US Military Hospital, Bethesda, MD
g, h, i) Yale’s and Allen Steere’s Congenital Lyme treatment failure
reports:
4003991; Maternal-fetal transmission of the Lyme disease spirochete,
Borrelia burgdorferi.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=4003991[uid]
3130607; Borrelia burgdorferi in a newborn despite oral penicillin for
Lyme borreliosis during pregnancy:
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=3130607[uid]
"The death of the newborn was probably due to respiratory failure
as a consequence of perinatal
brain damage."-- Yale Department of Pathology.
3480464; Stillbirth following maternal Lyme Disease (Willy
Burgdorfer, SUNY)
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=3480464[uid]
Of course, Yale and UConn now say that “Lyme Disease” is “not a
problem in pregnancy.” Well, sure, if they have redefined Lyme to
only an autoimmune arthritis in a knee. No one would say a hangnail,
carpal tunnel, or a stubbed toe affected pregnancies either.
j) CDC, Mayo Clinic, SUNY, Tulane Autopsy Reports: (Dr. Kenneth B.
Liegner, Armonk, NY):
4 cases studies wherein the victims were treated multiple times
with antibiotics; the tissues sent to the above 4 labs; all came back
positive by staining or DNA for Borrelia spirochetes. (Journal of
Spirochetal and Tick Borne Diseases, Lyme Disease Foundation, www.Lyme.org
)
k) 1989 IDSA Reviews, SUNY’s Raymond Dattwyler and Benjamin Luft
quoting Lenny Sigal and Allen Steere:
2682965 A perspective on the treatment of Lyme borreliosis.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=2682965[uid]
“Clinical studies have documented the efficacy of antibiotics, but
therapy has failed in as many as 50% of cases of chronic infection.
Although new antibiotic regimens appear promising, the optimal
treatment of this infectious disease remains to be determined.”
What happened was that once BigInsurance saw this series of reports by
IDSA in 1989, they freaked out and decided they were “just taking over
medicine and the MDs had better just get used to the idea.”—John J.
Connolly, former president of the Catholic Medical School, New York
Medical College, who sold out the college to Kaiser-Permanente…
Kaiser-Permanente, you can verify independently, is still at NYMC
literally training MDs.
This statement on record by John J. Connolly is on record at the New
Haven USDOJ… collecting dust.
l) CDC Officer Alan Barbour in 1986 stating that neurotropism
(spirochetes going after nerve tissue for a meal and a home) was not
trivial, that spirochetes were formally stored in rodent brains and
that a treatment for neurosyphilis that he recommends would be to
treat the patient with Relapsing Fever spirochetes: 3540570 The
Biology of Borrelia Species
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=3540570
“When using borreliae for pyrotherapy (induce a fever) of
neurosyphilis, the authors of this report recommend that no more than
30-40 passages in mice be made before inoculation of the strain into
humans.”
"The propensity for borrelia to go to the brain of infected mammals
suggests that the relationship between these spirochetes and neural
tissues is not trivial. Further study of this attraction and the
interaction that follows may reveal the basis for the significant
nerve and brain involvement in Lyme borreliosis"—
This from a CDC officer who now says “Lyme Disease is easily diagnosed
and cured?” Why wouldn’t he recommend antibiotics?
m) Dattwyler, Benach, Pachner and “early brain invasion”:
i) Dattwyler at the 1994 June, FDA Meeting Minutes/Transcript
regarding OspA Lyme vaccines:
“Ben Luft and myself, and a number of our colleagues, have looked at
early CNS invasion using PCR, and found that, in individuals with
multiple erythema migrans rashes, or a single lesion or erythema
migrans and major constitutional symptoms, about 2/3rds of those
individuals will have Borrelia burgdorferi DNA in their cerebrospinal
fluid, which we take as evidence of early central nervous system
invasion of this organism.”
Now, UConn and Yale – and the BigInsurance companies they prostitute
for - maintain that “Lyme only happens in your knee,” because knee
diseases do not require the expensive intravenous ceftriaxone. Brain
diseases require intravenous medications because that is the modality
for bacterial meningitis, the efficacy of which depends on maintaining
a high concentration of the drug in the blood. High concentrations of
antibiotics into the area of the brain and meninges is just not
achieved with oral antibiotics.
ii) 2215944; Borrelia burgdorferi infection of the brain:
characterization of the organism and response to antibiotics and
immune sera in the mouse model.- Andrew Pachner
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=2215944[uid]
Organism was cultured from the brain early in the course of
infection, and this isolate, named N40Br, was further studied in
vitro. The plasmid content of N40Br was different from that of the
infecting strain, implying either a highly selective process during
infection or DNA rearrangement in the organism in vivo.
2345299; Borrelia burgdorferi in the central nervous system:
experimental and clinical evidence for early invasion. Jorge Benach
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=2345299[uid]
This experimental evidence for early central nervous system
invasion was pursued in studies of the human disease. Specific B.
burgdorferi antigens could be detected in the cerebrospinal fluid of
patients with early Lyme disease by use of murine monoclonal
antibodies as probes.
It is therefore indisputable that Lyme Borreliosis is a disease of the
brain and not of the knee.
n) IDSA staff referring to a report by University of Rhode Island
where within one minute after the addition of whole rabbit blood, the
spirochetal cyst form reverted back to the intact spirochete form
(IDSA/Yale/UConn falsely claim that the cyst or the spheroplast form
is an end-stage or an “almost dead” stage, when in fact, it has been
well-known through history to be a dormant phase):
10658658; Serum-starvation-induced changes in protein synthesis and
morphology of Borrelia burgdorferi.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=10658658[uid]
UConn, Yale and NYMC IDSA crooks – the cabal sued by Mr. Blumenthal -
referring to the above report:
http://scholar.google.com/scholar?q=link:http://mic.sgmjournals.org/cgi/content/abstract/146/1/119
meaning they read it;
and in fact the US Army advises soldiers to be careful not to inhale
spirochetal cysts when around dried animal urine; US Army Manual
(LEPTOSPIROSIS):
http://www.afpmb.org/pubs/dveps/haiti.pdf
o) Russell Johnson discusses in his article in the 1989 Infectious
Disease Reviews (the name of IDSA’s former journal) how it can take a
few months to reculture the spheroplast form of the spirochete back
into the intact spirochete form:
2682963 Isolation techniques for spirochetes and their sensitivity to
antibiotics in vitro and in vivo.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=2682963[uid]
IDSA fraudulently claims that if Borrelia are not re-grown from
human spinal fluid after 3 weeks, there is no Borrelia present.
See the Klempner report, which is the basis of IDSA's
"guidelines."
You can see for yourself that it's all bullshit.
3) THE PRIMERS SHELL GAME and RELAPSING FEVER:
The vaccines and test kit candidates this cabal intended to corner the
market on (in grant money or free, taxpayer-funded venture capital for
their biotech products in addition to manipulating “disease
definitions” on behalf of BigInsurance) required patenting sections of
DNA to be spliced into E coli and the like (“Biologics”). They call
these sections of DNA – that they OWN- recombinants.
Recombinant OspA or recombinant Pam3Cys comes from plasmid DNA and not
the single linear chromosome that is the main DNA code for these
spirochetes. The plasmid DNA is VARIABLE DNA or the DNA that changes
as a result of the mechanism by which Relapsing Fever Borrelia – the
genus to which Lyme Disease belongs – are, in fact Relapsing Fever
organisms.
That is, through variation in this plasmid DNA, the spirochetes change
their outer surface proteins (Osps, like OspA, like LYMErix, or the
HIV glycoproteins gp 120 and gp 41) rendering antibodies no good, or
the patient relapses.
Antibodies do no good and neither do vaccines, obviously.
Taxonomically, the differences in the Relapsing Fever spirochetes –
since the differences can’t be in the variable plasmid DNA – is in the
non-variable backbone, if you will, of spirochetes, the flagellin.
So, all spirochetes are categorized by differences in their flagellin.
The UConn/Yale crooks are aware of this, but most MDs are not.
Whenever Yale/UConn and the other members of this cabal want to find
spirochetes to patent, they search ticks using flagellin DNA primers
(or amplimers, or a short DNA template), or they use other BORRELIA-
SPECIFIC RNA, like the BORRELIA SPECIFIC intragenic spacer RNA.
When these crooks pretend to be looking for Borrelia DNA in humans,
they use the wrong primers. They use the bogus variable DNA primers
like OspA. They also insist that there is no “Lyme Disease” in areas
where they know there are other Relapsing Fever spirochetes.
In short, according to this criminal gang, if people don’t have the
OspA gene, they don’t have “Lyme Disease” and don’t need to be
treated.
I hope you can follow this shell game:
When looking for spirochetal DNA in ticks to patent, these
criminals use the correct primers.
When they want to find “No Lyme,” they use the wrong primers; the
look for a DNA sequence that they know is unlikely to be there in a
patient.
You can see the BigInsurance influence in this game. Their bottom
line is all about not identifying and then being obligated to treat
anything.
Here are the PubMed articles and patent numbers that prove UConn, et
al, know which are the correct primers to use to find Borrelia
spirochetes- but have never been used in treatment outcomes for
humans:
US PATENTS
5, 618, 533 - Yale’s Flagellin method, which is the only
scientifically valid test for Lyme Borreliosis; it is not in use,
licensed by no one, and Yale did not use this patented method to
assess their other patent, LYMErix, because they knew LYMErix did not
prevent Lyme.
6, 045, 804 - The Central RICO patent and the associated report
worked on by Yale’s Robert Schoen; in this patent Schoen et al,
demonstrate that they know which RNA primers to use to detect OspA-
Borrelia. The patent was applied for in 1996, developed in at least
1995, and in it they describe 1) How they can’t read their Western
Blots in LYMErix-vaccinated people (meaning, they have no way to prove
LYMErix prevented Lyme), and 2) vaccine failure is indistinguishable
from chronic neurologic Lyme Borreliosis.
But they never told anyone. And this is important, because we later
found out the reason chronic neurologic Lyme was the New Great
Imitator was the result of Pam3Cys or OspA-induced immune suppression
and the activation of latent viruses of all kinds (MS and Cancer) in
addition to tolerance to fungal antigens (ALS and Chronic Fatigue
Syndrome).
In other words, “LYMErix Disease” – the diseases set caused by chronic
Lyme and LYMErix - is the Yuppie AIDS, or acquired immune
deficiencies.
It’s a huge crime. The Nobel Prize winner for the discovery of the
HIV virus, Luc Montagnier, is now following up on why the LYMErix
Pam3Cys vaccine failed, because it is the same antigen as the HIVgp120
failed vaccine, generally, Pam3Cys (different amino acids, but the
general structure is the same).
Imagine what would have happened if Yale and UConn had been honest
about this 10 years ago?
5, 932, 220 B. Theileri-Come-Mastersi-Come-Barbouri. This is a
patent for Borrelia found in Lone Star Ticks, which is also known as
Southern Lyme Disease or Master’s Disease, or STARI. Gary Wormser of
New York Medical College says this is not “Lyme Disease,” not
informing people that this patent is for a cow-relapsing fever that
infects humans through a Lone Star Tick. The patent is for flagellin,
because these crooks know that differences in flagellin are the
demarcation for different species.
However, they- Yale, UConn, and the cabal - say repeatedly in public,
that the human victims of this disease do not have “Lyme Disease” and
are therefore not sick and need no treatment. They’re ALL Relapsing
Fever organisms. “Lyme Disease” is just chapter one of probably a 50
year roll-out plan where we only learn about a new disease after the
vaccine has been fraudulently qualified. In the meanwhile these
crooks say we’re CRAZY – denying us medical care and long-term
disability coverage from our employers - when in fact, we do have a
real brain disease. ‘One that needs intravenous ceftriaxone,
relapsingly.
EUROPEAN PATENTS: WO9324145
CDC staff members own patents in Europe with SmithKline, in which they
prove that they know that the arthritis-only kind of Lyme or UConn’s
and Yale’s fraudulent definition of Lyme or the Dearborn kind of Lyme
is not the only kind of Lyme:
http://v3.espacenet.com/inpadoc?submitted=true&DB=EPODOC&CC=WO&NR=9324145&KC=&F=8&OREQ=0&textdoc=TRUE&FT=E
Summary of the Invention In one aspect, the invention provides
isolated B. burgdorferi antigens which are regulated and
differentiated by growth of the B. burgdorferi in a tick vector. Novel
antigens of the invention are listed below in Table I.
Certain of these antigens are characterized as being B.
burgdorferi B31 strain specific and major histocompatibility complex
(MHC) nonrestricted. Certain other of these antigens are characterized
as being MHCrestricted. Sera generated to these antigens (B31 MHC
nonrestricted and B31 MHC restricted) are further characterized by the
ability or lack of ability to react with B. burgdorferi JD-1 strain;
the antigens themselves (B31 MHC nonrestricted and B31 MHC restricted)
are further characterized by being homologous or heterologous with B.
burgdorferi JD-1 strain antigens. The most preferred antigens of this
invention, because of their ability to induce cross-strain immunity to
B. burgdorferi in different animal haplotypes, are characterized by
being B31 MHC nonrestricted, JD-1 crossreactive, and JD-1
nonrestricted.Other antigens are also useful in vaccine compositions
and as diagnostics.
That’s long for: “There are 2 kinds of Lyme. Yale’s
hypersensitivity reaction to OspA, over which SmithKline was sued in
two class actions and Yale, et al, was later sued by the CT AG, and
Neuroborreliosis, a disease denied because we, the CDC, are also
profiteering, lying crooks and are in on the scam.”
THE PUBMED REPORTS ASSOCIATED WITH THE PRIMERS SHELL GAME:
The following reports are by members of the RICO cabal that show that
they know that they’re playing a DNA shell game, and that they KNOW
which are the correct, unchanging, Borreliae-specific DNA or RNA
primers.
PubMed ID: 8968914; Borrelia burgdorferi enzyme-linked immunosorbent
assay for discrimination of OspA vaccination from spirochete
infection. -- Yale’s Robert Schoen, and Dave Persing of the Mayo
Clinic (at that time), members of the RICO cabal.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=8968914[uid]
This 1996 report by this RICO gang pretty much knows how to detect
any kind of Borrelia anywhere. But no one is allowed to have a
“disease” unless they have a bad knee from a hypersensitivity response
to OspA, the vaccine. Here they state that they distinguish Borrelia
from species specific 23S ribosomal RNA, or the intragenic spacers
that are unique to Borrelia burgdorferi.
Such a method has never been used on treatment outcomes in humans. No
one who has this devastating disease, Borreliosis or Relapsing Fever,
happens to care if they have Yale’s patented OspA kind of “Lyme
Disease.” (I don’t care if I have Borrelia outermongolii or Borrelia
antarcticii or Borrelia whopperburgerii, or Borrelia gimmeabreakii, if
you know what I mean.) In the National Library of Medicine Taxonomy
database, there are about 160 strains of Relapsing Fever listed, 30
specific to California alone. But, according to IDSA, “there is no
Lyme Disease in California.”
Taxonomy Database (look how many strains say "CA" for California in
front of them)
http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=138
About 40 "CA" strains listed.
This would be particularly true because Kaiser-Permanente basically
owns California, and hence the nickname, Kaiserfornia. New York
Medical College is their New England “forward base,” so to speak.
And finally, here is Gary Wormser of New York Medical College using,
the one and only time, the correct RNA or DNA primers to determine
that antibiotic treatment of a tick bite fails to kill all the
spirochetes in 2/9 cases:
1452688; 1992; Diagnosis of early Lyme disease by polymerase chain
reaction amplification and culture of skin biopsies from erythema
migrans lesions.
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=1452688[uid]
In this 1992 study, Gary Wormser published that he knows which are
the correct primers to use when he wants to find spirochetes. He
found through biopsy that among 9 patients who were treated with
antibiotics right after tick attachment, that there was still
spirochetal RNA in the skin of at least 2 of them.
This study, where the CORRECT RNA or DNA primers were used, has never
been repeated in an IDSA antibiotic treatment study, and this cabal
now publicly states that no one needs to be treated upon tick
attachment.
‘Despite knowing these spirochetes go right to the brain, and the
infection is permanent.
So, in summary, there is plenty of reason to dispute funding a 600
million dollar hospital for crooks who work with BigInsurance against
patient care and who participated in this huge, international Pam3Cys-
HIV vaccine failure fiasco costing the world at least 10 years in
wasted lives and money.
======================================
4) INTRACELLULAR, VIABLE, REPLICATING CYST OR SPHEROPLAST FORMS:
Question: If spirochetes, when driven into the cyst form, replicate,
do we end up with
even more spirochetes than we would have had we not taken antibiotics?
--1983, Proposed Life Cycle for the Reiter Treponeme (validity of
"cysts," or spheroplasts or regeneration forms)
--- From the Plum Stupid Island Chapter of Cryme Disease
1911: ...It will perhaps be remembered that one found
intracorpuscular forms in this fowl spirochaetosis, and that following
Sambon, one had to come to the conclusion that these endoglobular
bodies represented a stage in the lifecycle of the spirochaete --
constituted, in short, its stage of schizogony in the fowl. Sambon,
however, who expressed this view from the study of a few slides I gave
him, did not indicate how this red cell invasion occurred. For a long
time I believed the spirochaetes themselves entered the red cells and
broke up, or coiled up, within them to form these remarkable bodies.
As the parasites can and do enter and leave the erythroblasts of the
fowl, there was good ground for this supposition. Now however, I know
better.
--- From The History of Relapsing Fever Chapter of Cryme
Disease
The CDC says spirochetes are intracellular in 2006:
http://www.ncbi.nlm.nih.gov/pubmed/17045505?ordinalpos=13&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum
Invasion of human neuronal and glial cells by an infectious strain of
Borrelia burgdorferi.
--- From the Bogus Russian Scientists Publishing Garbage at
New York Medical College Chapter of Cryme Disease
-- 1971 Russian Scientists on the viability of intracellular cysts:
Full Text scanned in
http://www.pubmedcentral.nih.gov/picrender.fcgi?artid=1048219&blobtype=pdf
"[Real] scientists are *fiercely* independent. That's the good
news."-- NIH's Top Fool, Anthony Fauci |
|
|
| Back to top |
|
|
|
|
|
All times are GMT - 5 Hours
The time now is Fri Dec 11, 2009 10:23 pm
|
|